MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis

Mutation Research - Reviews in Mutation Research

Volumn 751, Issue 2, 2012, Pages 287-303

  Izzotti, Alberto ^a   Cartiglia, Cristina ^a   Steele, Vernon E ^b   De Flora, Silvio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemoprevention; Dietary agents; MicroRNA; Pharmacological agents

Indexed keywords

3 INDOLEMETHANOL; ANTHOCYANIN; ANTHRAQUINONE; ANTIINFLAMMATORY AGENT; BEXAROTENE; CARCINOGEN; CURCUMIN; ELLAGITANNIN; EPIGALLOCATECHIN GALLATE; ERGOCALCIFEROL; FLAVONOL; FOLIC ACID; GENISTEIN; HISTONE DEACETYLASE INHIBITOR; INDOLE; INDOLE DERIVATIVE; ISOFLAVONE; ISOTHIOCYANIC ACID; MICRORNA; PHENETHYL ISOTHIOCYANATE; PHOSPHOLIPID; PIOGLITAZONE; POLYUNSATURATED FATTY ACID; RESVERATROL; RETINOIC ACID; SAPONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THIOL; TOCOPHEROL; UNINDEXED DRUG;

CANCER CELL; CARCINOGENESIS; CHEMOPROPHYLAXIS; HUMAN; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIMUTAGENIC AGENTS; CHEMOPREVENTION; DIET; HUMANS; MICRORNAS; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; VITAMINS;

MUS; RATTUS;

EID: 84865642467     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2012.05.004     Document Type: Review

References (121)

1. Kim V.N., Nam J.W. Genomics of microRNA. Trends Genet. 2006, 22:165-173.
2. Berezikov E., Cuppen E., Plasterk R.H. Approaches to microRNA discovery. Nat. Genet. 2006, 38:S2-S7.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol. 2005, 3:e85.
5. Di Leva G., Croce C.M. Roles of small RNAs in tumor formation. Trends Mol. Med. 2010, 16:257-267.
6. Couzin J. MicroRNAs make big impression in disease after disease. Science 2008, 319:1782-1784.
7. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
8. Wouters M.D., van Gent D.C., Hoeijmakers J.H., Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat. Res. 2011, 717:54-66.
9. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
10. Pothof J., Verkaik N.S., van IJcken W., Wiemer E.A., Ta V.T., van der Horst G.T., Jaspers N.G., van Gent D.C., Hoeijmakers J.H., Persengiev S.P. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J. 2009, 28:2090-2099.
11. Duan H., Jiang Y., Zhang H., Wu Y. MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol. In Vitro 2010, 24:928-935.
12. Elamin B.K., Callegari E., Gramantieri L., Sabbioni S., Negrini M. MicroRNA response to environmental mutagens in liver. Mutat. Res. 2011, 717:67-76.
13. Lema C., Cunningham M.J. MicroRNAs and their implications in toxicological research. Toxicol. Lett. 2010, 198:100-105.
14. Izzotti A., Calin G., Arrigo P., Steele V.E., Croce C., De Flora S. Downregulation of microRNA expression in the lung of rats exposed to cigarette smoke. FASEB J. 2009, 23:806-812.
15. Izzotti A., Calin G.A., Steele V.E., Croce C.M., De Flora S. Relationship of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 2009, 23:3243-3250.
16. Jardim M.J. MicroRNAs: implications for air pollution research. Mutat. Res. 2011, 1:38-45.
17. Sonkoly E., Pivarcsi A. MicroRNAs in inflammation and response to injuries induced by environmental pollution. Mutat. Res. 2011, 717:46-53.
18. De Flora S., Ramel C. Mechanisms of inhibitor of mutagenesis and carcinogenesis. Classification and overview. Mutat. Res. 1988, 202:285-306.
19. Kelloff G.J., Boone C.W., Steele V.E., Crowell J.A., Lubet R.A., Greenwald P., Hawk E.T., Fay J.R., Sigman C.C. Mechanistic considerations in the evaluation of chemopreventive data. IARC Sci. Publ. 1996, 139:203-219.
20. De Flora S., Ferguson L.R. Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 2005, 591:8-15.
21. Zhang W., Dolan M.E. Emerging role of microRNAs in drug response. Curr. Opin. Mol. Ther. 2010, 12:695-702.
22. Davis C.D., Ross S.A. Evidence for dietary regulation of microRNA expression in cancer cells. Nutr. Rev. 2008, 66:477-482.
23. Li Y., Kong D., Wang Z., Sarkar F.H. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 2010, 27:1027-1041.
24. Link A., Balaguer F., Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem. Pharmacol. 2010, 80:1771-1792.
25. Reuter S., Gupta S.C., Park B., Goel A., Aggarwal B.B. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011, 6:93-108.
26. Parasramka M.A., Ho E., Williams D.E., Dashwood R.H. MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol. Carcinog. 2012, 51:213-230.
27. Chin L.J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., Muller R.U., Straka E., Su L., Burki E.A., Crowell R.E., Patel R., Kulkarni T., Homer R., Zelterman D., Kidd K.K., Zhu Y., Christiani D.C., Belinsky S.A., Slack F.J., Weidhaas J.B. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res. 2008, 68:8535-8540.
28. Gong J., Tong Y., Zhang H.M., Wang K., Hu T., Shan G., Sun J., Guo A.Y. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum. Mutat. 2011, 33:254-263.
29. Rossi A., D'Urso O.F., Gatto G., Poltronieri P., Ferracin M., Remondelli P., Negrini M., Caporaso M.G., Bonatti S., Mallardo M. Non-coding RNAs change their expression profile after retinoid induced differentiation of the promyelocytic cell line NB4. BMC Res. Notes 2010, 3:24.
30. Garzon R., Pichiorri F., Palumbo T., Visentini M., Aqeilan R., Cimmino A., Wang H., Sun H., Volinia S., Alder H., Calin G.A., Liu C.G., Andreeff M., Croce C.M. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007, 26:4148-4157.
31. Jian P., Li Z.W., Fang T.Y., Jian W., Zhuan Z., Mei L.X., Yan W.S., Jian N. Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J. Hematol. Oncol. 2011, 4:20.
32. Terao M., Fratelli M., Kurosaki M., Zanetti A., Guarnaccia V., Paroni G., Tsykin A., Lupi M., Gianni M., Goodall G.J., Garattini E. Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J. Biol. Chem. 2011, 286:4027-4042.
33. Kawasaki H., Taira K. Functional analysis of microRNAs during the retinoic acid-induced neuronal differentiation of human NT2 cells. Nucleic Acids Res. Suppl. 2003, 3:243-244.
34. Das S., Foley N., Bryan K., Watters K.M., Bray I., Murphy D.M., Buckley P.G., Stallings R.L. MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Res. 2010, 70:7874-7881.
35. Beveridge N.J., Tooney P.A., Carroll A.P., Tran N., Cairns M.J. Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation. Cell Signal. 2009, 21:1837-1845.
36. Meseguer S., Mudduluru G., Escamilla J.M., Allgayer H., Barettino D. MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). J. Biol. Chem. 2011, 286:4150-4156.
37. Zhao J.J., Sun D.G., Wang J., Liu S.R., Zhang C.Y., Zhu M.X., Ma X. Retinoic acid downregulates microRNAs to induce abnormal development of spinal cord in spina bifida rat model. Childs Nerv. Syst. 2008, 24:485-492.
38. Kutay H., Bai S., Datta J., Motiwala T., Pogribny I., Frankel W., Jacob S.T., Ghoshal K. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem. 2006, 99:671-678.
39. Pogribny I.P., Tryndyak V.P., Ross S.A., Beland F.A. Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats. Nutr Rev. 2008, 66(Suppl. 1):S33-S35.
40. Wang L.L., Zhang Z., Li Q., Yang R., Pei X., Xu Y., Wang J., Zhou S.F., Li Y. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum. Reprod. 2009, 24:562-579.
41. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res. 2006, 66:10843-10848.
42. Wang X., Gocek E., Liu C.G., Studzinski G.P. MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 2009, 8:736-741.
43. Gocek E., Wang X., Liu X., Liu C.G., Studzinski G.P. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res. 2011, 71:6230-6239.
44. Peng X., Vaishnav A., Murillo G., Alimirah F., Torres K.E., Mehta R.G. Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J. Cell. Biochem. 2010, 110:1324-1333.
45. Mohri T., Nakajima M., Takagi S., Komagata S., Yokoi T. MicroRNA regulates human vitamin D receptor. Int. J. Cancer 2009, 125:1328-1333.
46. Essa S., Denzer N., Mahlknecht U., Klein R., Collnot E.M., Tilgen W., Reichrath J. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. J. Steroid Biochem. Mol. Biol. 2010, 121:110-113.
47. Gaedicke S., Zhang X., Schmelzer C., Lou Y., Doering F., Frank J., Rimbach G. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 2008, 582:3542-3546.
48. Rimbach G., Moehring J., Huebbe P., Lodge J.K. Gene-regulatory activity of alpha-tocopherol. Molecules 2010, 15:1746-1761.
49. Sarveswaran S., Liroff J., Zhou Z., Nikitin A.Y., Ghosh J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: implication for the treatment of early-stage prostate cancer. Int. J. Oncol. 2010, 36:1419-1428.
50. Noratto G.D., Kim Y., Talcott S.T., Mertens-Talcott S.U. Flavonol-rich fractions of yaupon holly leaves (Ilex vomitoria, Aquifoliaceae) induce microRNA-146a and have anti-inflammatory and chemopreventive effects in intestinal myofibroblast CCD-18Co cells. Fitoterapia 2011, 82:557-569.
51. Ai R.T., Wu S.Y., Wen X.Y., Xu W., Lv L., Rao J.J., Wu S.G. 1,3,4-Tri-O-galloyl-6-O-caffeoyl-β-d-glucopyranose, a new anti-proliferative ellagitannin, regulates the expression of microRNAs in HepG(2) cancer cells. Nan Fang Yi Ke Da Xue Xue Bao 2011, 31:1641-1648.
52. Wen X.Y., Wu S.Y., Li Z.Q., Liu Z.Q., Zhang J.J., Wang G.F., Jiang Z.H., Wu S.G. Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of MiRNAs in HepG2 cancer cells. Phytother. Res. 2009, 23:778-784.
53. Tsang W.P., Kwok T.T. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 2010, 21:140-146.
54. Arola-Arnal A., Bladé C. Proanthocyanidins modulate microRNA expression in human HepG2 cells. PLoS One 2011, 6:e25982.
55. Fix L.N., Shah M., Efferth T., Farwell M.A., Zhang B. MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics 2010, 7:261-277.
56. Wang H., Bian S., Yang C.S. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizingHIF-1{alpha}. Carcinogenesis 2011, 32:1181-1189.
57. Sun M., Estrov Z., Ji Y., Coombes K.R., Harris D.H., Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 2008, 7:464-473.
58. Yang J., Cao Y., Sun J., Zhang Y. Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med. Oncol. 2010, 27:1114-1118.
59. * signaling pathway. Oncol. Rep. 2010, 24:1217-1223.
60. Mudduluru G., George-William J.N., Muppala S., Asangani I.A., Kumarswamy R., Nelson L.D., Allgayer H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep. 2011, 31:185-197.
61. Bao B., Ali S., Kong D., Sarkar S.H., Wang Z., Banerjee S., Aboukameel A., Padhye S., Philip P.A., Sarkar F.H. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One 2011, 6:e17850.
62. Tili E., Michaille J.J., Alder H., Volinia S., Delmas D., Latruffe N., Croce C.M. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem. Pharmacol. 2010, 80:2057-2065.
63. Tili E., Michaille J.J., Adair B., Alder H., Limagne E., Taccioli C., Ferracin M., Delmas D., Latruffe N., Croce C.M. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010, 31:1561-1566.
64. Tili E., Michaille J.J. Resveratrol, microRNAs, inflammation, and cancer. J. Nucleic Acids 2011, (Epub Aug 10). 10.4061/2011/102431.
65. Lukiw W.J., Zhao Y., Cui J.G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 2008, 283:31315-31322.
66. Han Z., Yang Q., Liu B., Wu J., Li Y., Yang C., Jiang Y. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol. Carcinogenesis 2012, 33:131-139.
67. Bae S., Lee E.M., Cha H.J., Kim K., Yoon Y., Lee H., Kim J., Kim Y.J., Lee H.G., Jeung H.K., Min Y.H., An S. Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol. Cells 2011, 32:243-249.
68. Dhar S., Hicks C., Levenson A.S. Resveratrol and prostate cancer: promising role for microRNAs. Mol. Nutr. Food Res. 2011, 55:1219-1229.
69. Mukhopadhyay P., Mukherjee S., Ahsan K., Bagchi A., Pacher P., Das D.K. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One 2010, 5:e15705.
70. Mukhopadhyay P., Das S., Gorbunov N., Ahsan M.K., Otani H., Pacher P., Das D.K. Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischemic myocardium and synergestic effects of resveratrol and γ-tocotrienol. J. Cell. Mol. Med. 2011, (Epub ahead of print). 10.1111/j.1582-4934.2011.01480.
71. Sun Q., Cong R., Yan H., Gu H., Zeng Y., Liu N., Chen J., Wang B. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol. Rep. 2009, 22:563-567.
72. Li Y., Sarkar F.H. Down-regulation of invasion and angiogenesisrelated genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett. 2002, 186:157-164.
73. Parker L.P., Taylor D.D., Kesterson J., Metzinger D.S., Gercel-Taylor C. Modulation of microRNA associated with ovarian cancer cells by genistein. Eur. J. Gynaecol. Oncol. 2009, 30:616-621.
74. Majid S., Dar A.A., Saini S., Chen Y., Shahryari V., Liu J., Zaman M.S., Hirata H., Yamamura S., Ueno K., Tanaka Y., Dahiya R. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010, 70:2809-2818.
75. Chen Y., Zaman M.S., Deng G., Majid S., Saini S., Liu J., Tanaka Y., Dahiya R. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res. 2011, 4:76-86.
76. Rabiau N., Trraf H.K., Adjakly M., Bosviel R., Guy L., Fontana L., Bignon Y.J., Bernard-Gallon D.J. miRNAs differentially expressed in prostate cancer cell lines after soy treatment. In Vivo 2011, 25:917-921.
77. Gou J.Y., Felippes F.F., Liu C.J., Weigel D., Wang J.W. Negative regulation of anthocyanin biosynthesis in Arabidopsis by a miR156-targeted SPL transcription factor. Plant Cell 2011, 23:1512-1522.
78. Li Y., VandenBoom T.G., Kong D., Wang Z., Ali S., Philip P.A., Sarkar F.H. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009, 69:6704-6712.
79. Jin Y., Zou X., Feng X. 3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells. Anticancer Drugs 2010, 21:814-822. (Retraction in: Anticancer Drugs 22 (2011) 303).
80. Melkamu T., Zhang X., Tan J., Zeng Y., Kassie F. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis 2010, 31:252-258.
81. Izzotti A., Calin G.A., Steele V.E., Cartiglia C., Longobardi M., Croce C.M., De Flora S. Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev. Res. 2010, 3:62-72.
82. Izzotti A., Larghero P., Cartiglia C., Longobardi M., Pfeffer U., Steele V.E., De Flora S. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010, 31:894-901.
83. Izzotti A., Larghero P., Balansky R., Pfeffer U., Steele V.E., De Flora S. Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung. Mutat. Res. 2011, 717:17-24.
84. Wu N., Wu G.C., Hu R., Li M., Feng H. Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacol. Sin. 2011, 32:345-353.
85. Chen W.S., Hou J.N., Guo Y.B., Yang H.L., Xie C.M., Lin Y.C., She Z.G. Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway. J Exp. Clin. Cancer Res. 2011, 8:30. 17.
86. Davidson L.A., Wang N., Shah M.S., Lupton J.R., Ivanov I., Chapkin R.S. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 2009, 30:2077-84.S.
87. Tzur G., Levy A., Meiri E., Barad O., Spector Y., Bentwich Z., Mizrahi L., Katzenellenbogen M., Ben-Shushan E., Reubinoff B.E., Galun E. MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS One 2008, 3:e3726.
88. Hu S., Dong T.S., Dalal S.R., Wu F., Bissonnette M., Kwon J.H., Chang E.B. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS One 2011, 6:e16221.
89. Ye Y., Hu Z., Lin Y., Zhang C., Perez-Polo J.R. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc. Res. 2010, 187:535-544.
90. Shin S., Lee E.M., Cha H.J., Bae S., Jung J.H., Lee S.M., Yoon Y., Lee H., Kim S., Kim H., Lee S.J., Park I.C., Jin Y.W., An S. MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells. Int. J. Oncol. 2009, 35:1343-1352.
91. Kretzner L., Scuto A., Dino P.M., Kowolik C.M., Wu J., Ventura P., Jove R., Forman S.J., Yen Y., Kirschbaum M.H. Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. Cancer Res. 2011, 71:3912-3920.
92. Nalls D., Tang S.N., Rodova M., Srivastava R.K., Shankar S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One 2011, 6:e24099.
93. Lee E.M., Shin S., Cha H.J., Yoon Y., Bae S., Jung J.H., Lee S.M., Lee S.J., Park I.C., Jin Y.W., An S. Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int. J. Mol. Med. 2009, 24:45-50.
94. Rhodes L.V., Nitschke A.M., Segar H.C., Martin E.C., Driver J.L., Elliott S., Nam S.Y., Li M., Nephew K.P., Burow M.E., Collins-Burow B.M. The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncol. Rep. 2012, 27:10-16.
95. Scott G.K., Mattie M.D., Berger C.E., Benz S.C., Benz C.C. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 2006, 66:1277-1281.
96. Williams A.E., Larner-Svensson H., Perry M.M., Campbell G.A., Herrick S.E., Adcock I.M., Erjefalt J.S., Chung K.F., Lindsay M.A. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009, 4:e5889.
97. Pathi S.S., Jutooru I., Chadalapaka G., Sreevalsan S., Anand S., Thatcher G.R., Safe S. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol. Cancer Res. 2011, 9:195-202.
98. Zhao J.J., Lin J., Yang H., Kong W., He L., Ma X., Coppola D., Cheng J.Q. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J. Biol. Chem. 2008, 283:31079-31086.
99. Miller T.E., Ghoshal K., Ramaswamy B., Roy S., Datta J., Shapiro C.L., Jacob S., Majumder S. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J. Biol. Chem. 2008, 283:29897-29903.
100. Cittelly D.M., Das P.M., Spoelstra N.S., Edgerton S.M., Richer J.K., Thor A.D., Jones F.E. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol. Cancer 2010, 9:317.
101. Rao X., Di Leva G., Li M., Fang F., Devlin C., Hartman-Frey C., Burow M.E., Ivan M., Croce C.M., Nephew K.P. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011, 30:1082-1097.
102. Ziouzenkova O., Plutzky J. Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett. 2008, 582:32-38.
103. De Flora S., Izzotti A., D'Agostini F., Balansky R.M. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001, 22:999-1013.
104. Kensler T.W., Egner P.A., Dolan P.M., Groopman J.D., Roebuck B.D. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 1987, 47:4271-4277.
105. De Flora S., D'Agostini F., Balansky R., Camoirano A., Bennicelli C., Bagnasco M., Cartiglia C., Tampa E., Longobardi M.G., Lubet R.A., Izzotti A. Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis. Mutat. Res. 2003, 523-524:237-252.
106. Weng J.R., Omar H.A., Kulp S.K., Chen C.S. Pharmacological exploitation of indole-3-carbinol to develop potent antitumor agents. Mini Rev. Med. Chem. 2010, 10:398-404.
107. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010, 5:e10615.
108. Hu H., Gatti R.A. MicroRNAs: new players in the DNA damage response. J. Mol. Cell Biol. 2011, 3:151-158.
109. Ligorio M., Izzotti A., Pulliero A., Arrigo P. Mutagens interfere with microRNA maturation by inhibiting DICER. An in silico biology analysis. Mutat. Res. 2011, 717:116-128.
110. Izzotti A., Larghero P., Longobardi M., Cartiglia C., Camoirano A., Steele V.E., De Flora S. Dose-responsiveness and persistence of microRNA expression alterations induced by cigarette smoke in mouse lung. Mutat. Res. 2011, 717:9-16.
111. Duan R., Pak C., Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet. 2007, 16:1124-1131.
112. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2999-3004.
113. Schembri F., Sridhar S., Perdomo C., Gustafson A.M., Zhang X., Ergun A., Lu J., Liu G., Zhang X., Bowers J., Vaziri C., Ott K., Sensinger K., Collins J.J., Brody J.S., Getts R., Lenburg M.E., Spira A. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2319-2324.
114. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., Zeng Y., Miao R., Jin G., Ma H., Chen Y., Shen H. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 2008, 118:2600-2608.
115. Osada H., Takahashi T. Let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci. 2011, 102:9-17.
116. Negrini M., Gramantieri L., Sabbioni S., Croce C.M. MicroRNA involvement in hepatocellular carcinoma. Anticancer Agents Med. Chem. 2011, 11:500-521.
117. Qi P., Cheng S.Q., Wang H., Li N., Chen Y.F., Gao C.F. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011, 6:e28486.
118. Izzotti A., Bagnasco M., Cartiglia C., Longobardi M., Camoirano A., Tampa E., Lubet R.A., De Flora S. Modulation of multigene expression and proteome profiles by chemopreventive agents. Mutat. Res. 2005, 591:212-223.
119. Izzotti A., Bagnasco M., Cartiglia C., Longobardi M., Balansky R.M., Merello A., Lubet R.A., De Flora S. Chemoprevention of genome, transcriptome, and proteome alterations induced by cigarette smoke in rat lung. Eur. J. Cancer 2005, 41:1864-1874.
120. Perdomo C., Spira A., Schembri F. MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat. Res. 2011, 717:32-37.
121. Etheridge A., Lee I., Hood L., Galas D., Wang K. Extracellular microRNA: a new source of biomarkers. Mutat. Res. 2011, 717:85-90.